Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | DHODH | Q02127 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CDC25B | P30305 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.46 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15081115 | 1.00 | KMO (0.61) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL131998 | 1.00 | KMO (0.61) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL12551713 | 1.00 | KMO (0.61) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL10039121 | 0.98 | KMO (0.59) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL131991 | 0.98 | KMO (0.59) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL134060 | 0.95 | KMO (0.69) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL12551712 | 0.95 | KMO (0.69) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL12551710 | 0.95 | KMO (0.69) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL12551723 | 0.95 | KMO (0.69) | KMOEGFRDHODHALDH1A1ATM | |
| SCHEMBL12551791 | 0.95 | KMO (0.69) | KMOEGFRDHODHALDH1A1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3005433-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2023-02-22 | — | — | EP | disclosed |
| US-11535640-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| US-11024815-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| EP-3658564-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2021-05-19 | — | — | EP | disclosed |
| US-10971689-B2 | Triphenylene-based materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-04-06 | — | — | US | disclosed |
| EP-3507294-B1 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-02-24 | — | — | EP | disclosed |
| EP-3526228-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-11-25 | — | — | EP | disclosed |
| EP-3515925-B1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
| EP-3526226-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2020-07-22 | — | — | EP | disclosed |
| US-10714691-B2 | Formulations for the production of electronic devices | MERCK PATENT GMBH (DE) | 2020-07-14 | — | — | US | disclosed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110108818-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| EP-2307520-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | Merck Patent GmbH (DE) | 2011-04-13 | — | — | EP | disclosed |
| WO-2011032686-A1 | FORMULAS FOR PRODUCING ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-03-24 | — | — | WO | disclosed |
| WO-2010102706-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2010-09-16 | — | — | WO | disclosed |
| WO-2010069442-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010006680-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | disclosed |
| WO-2010006680-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11024815-B2 | Metal complexes | EXOC4, EXOC3, TIMCC | KMO 1536/4885EGFR 2706/4885DHODH 3418/4885 |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, SLCO4C1, GJA1 | KMO 2354/4885EGFR 1880/4885DHODH 3617/4885 |
| US-11535640-B2 | Metal complexes | IMMT, MCU, SOD1 | KMO 3204/4885EGFR 3784/4885DHODH 3251/4885 |
| US-10971689-B2 | Triphenylene-based materials for organic electroluminescent devices | TERT, PIEZO1, EFNA1 | KMO 2907/4885EGFR 3397/4885DHODH 2295/4885 |
| US-10714691-B2 | Formulations for the production of electronic devices | NR3C2, KCNE1, NR2E1 | KMO 656/4885EGFR 1299/4885DHODH 4395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.